======= CACYBP ======= == Gene Information == * **Official Symbol**: CACYBP * **Official Name**: calcyclin binding protein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=27101|27101]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9HB71|Q9HB71]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CACYBP&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CACYBP|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606186|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a calcyclin binding protein. It may be involved in calcium-dependent ubiquitination and subsequent proteosomal degradation of target proteins. It probably serves as a molecular bridge in ubiquitin E3 complexes and participates in the ubiquitin-mediated degradation of beta-catenin. Two alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: May be involved in calcium-dependent ubiquitination and subsequent proteasomal degradation of target proteins. Probably serves as a molecular bridge in ubiquitin E3 complexes. Participates in the ubiquitin-mediated degradation of beta-catenin (CTNNB1). {ECO:0000269|PubMed:16085652}. |CS| |Siah-Interact N| |SGS| |nuclear envelope lumen| |beta-catenin destruction complex| |S100 protein binding| |response to growth hormone| |positive regulation of DNA replication| |tubulin binding| |SCF ubiquitin ligase complex| |cell body| |cellular response to calcium ion| |cardiac muscle cell differentiation| |response to leukemia inhibitory factor| |cellular response to leukemia inhibitory factor| |regulation of DNA replication| |cardiocyte differentiation| |response to calcium ion| |cardiac muscle tissue development| |cellular response to metal ion| |striated muscle cell differentiation| |cellular response to inorganic substance| |protein domain specific binding| |muscle cell differentiation| |aging| |striated muscle tissue development| |ubiquitin protein ligase binding| |muscle tissue development| |neuron projection| |response to metal ion| |response to peptide hormone| |response to peptide| |muscle structure development| |heart development| |response to inorganic substance| |circulatory system development| |protein homodimerization activity| |response to hormone| |negative regulation of cell death| |response to organonitrogen compound| |cellular response to cytokine stimulus| |response to nitrogen compound| |response to cytokine| |response to endogenous stimulus| |response to oxygen-containing compound| |regulation of cell death| |tissue development| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of biosynthetic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12867 * **Expression level (log2 read counts)**: 7.21 {{:chemogenomics:nalm6 dist.png?nolink |}}